Danaher Corporation (DHR) Financials
A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Oct 26, 2026; every other figure is from the SEC filings on this page. Not financial advice.
Newest figures come from the 10-Q for Q3 FY2026, filed Oct 21, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the DHR SEC filings page.
Danaher Corporation (DHR) reported $25.6B in revenue over the twelve months to Sep 25, 2026, up 5.5% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).
Danaher's 2025 revenue recovered modestly, but rising overhead kept operating profit and cash generation below FY2023 levels.
Between FY2023 and FY2025, revenue increased2.8% while operating income fell9.8% , revealing a margin squeeze rather than a volume-led earnings recovery. Over the same span, SG&A rose12.4% as operating margin fell 2.7 percentage points, so overhead absorbed the modest growth.
Operating cash flow of
Total liabilities rose
Financial Health Signals
Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →
Health score ≠ stock price. This rates the quality of Danaher Corporation's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.
Danaher Corporation has an operating margin of 19.1%, meaning the company retains $19 of operating profit per $100 of revenue. This strong profitability earns a score of 83/100, reflecting efficient cost management and pricing power. This is down from 20.4% the prior year.
Danaher Corporation's revenue grew a modest 2.9% year-over-year to $24.6B. This slow but positive growth earns a score of 35/100.
Danaher Corporation has a moderate D/E ratio of 0.35. This balance of debt and equity financing earns a leverage score of 32/100.
Danaher Corporation's current ratio of 1.87 indicates adequate short-term liquidity, earning a score of 55/100. The company can meet its near-term obligations, though with limited headroom.
Danaher Corporation converts 21.4% of revenue into free cash flow ($5.3B). This strong cash generation earns a score of 88/100.
Danaher Corporation's ROE of 6.9% shows moderate profitability relative to equity, earning a score of 62/100. This is down from 7.9% the prior year.
Danaher Corporation scores 4.53, well above the 2.99 safe threshold. The largest contribution to the score comes from a market capitalization of $163.8B against total liabilities of $30.9B. This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Danaher Corporation passes 5 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, neither operating efficiency signal passes.
For every $1 of reported earnings, Danaher Corporation generates $1.78 in operating cash flow ($6.4B OCF vs $3.6B net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.
Danaher Corporation earns $17.70 in operating income for every $1 of interest expense ($4.7B vs $265.0M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
Key Financial Metrics
Earnings & Revenue
Danaher Corporation generated $6.6B in revenue in Q3 2026. This represents an increase of 8.3% from the same quarter a year earlier. Against the prior quarter it is up 4.6%.
Danaher Corporation's EBITDA was $2.0B in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 10.7% from the same quarter a year earlier. Against the prior quarter it is up 10.1%.
Danaher Corporation reported $1.2B in net income in Q3 2026. This represents an increase of 36.0% from the same quarter a year earlier. Against the prior quarter it is up 42.0%.
Danaher Corporation earned $1.75 per diluted share (EPS) in Q3 2026. This represents an increase of 37.8% from the same quarter a year earlier. Against the prior quarter it is up 42.3%.
Cash & Balance Sheet
Danaher Corporation generated $1.6B in free cash flow in Q3 2026, representing cash available after capex. This represents an increase of 19.1% from the same quarter a year earlier. Against the prior quarter it is up 28.9%.
Danaher Corporation held $5.7B in cash against $24.4B in long-term debt as of Q3 2026.
Not reported for Q3 2026.
Margins & Returns
Danaher Corporation's gross margin was 58.5% in Q3 2026, indicating the percentage of revenue retained after direct costs. This is up 0.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.9 percentage points.
Danaher Corporation's operating margin was 19.0% in Q3 2026, reflecting core business profitability. This is down 0.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.0 percentage points.
Danaher Corporation's net profit margin was 18.8% in Q3 2026, showing the share of revenue converted to profit. This is up 3.8 percentage points from the same quarter a year earlier. Against the prior quarter it is up 5.0 percentage points.
Danaher Corporation's quarterly ROE was 2.3% in Q3 2026: one quarter's net income over shareholder equity, not annualized. This is up 0.5 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.6 percentage points.
Capital Allocation
Danaher Corporation invested $433.0M in research and development in Q3 2026. This represents an increase of 14.6% from the same quarter a year earlier. Against the prior quarter it is up 5.1%.
Danaher Corporation repurchased no shares in Q3 2026. This represents a decrease of 100.0% from the same quarter a year earlier. Against the prior quarter it is down 100.0%.
Danaher Corporation invested $255.0M in capex in Q3 2026, funding long-term assets and infrastructure. This represents a decrease of 12.7% from the same quarter a year earlier. Against the prior quarter it is down 5.2%.
DHR Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Revenue | $6.6B+8.3% | $6.3B+5.5% | $6.0B+3.7% | $6.8B+4.6% | $6.1B+4.4% | $5.9B+3.4% | $5.7B-0.9% | $6.5B+2.1% |
| Cost of Revenue | $2.7B+7.4% | $2.7B+10.0% | $2.4B+5.8% | $2.9B+8.5% | $2.5B+5.5% | $2.4B+4.2% | $2.2B-3.4% | $2.6B |
| Gross Profit | $3.8B+8.9% | $3.6B+2.5% | $3.6B+2.3% | $4.0B+2.0% | $3.5B+3.6% | $3.5B+2.8% | $3.5B+0.7% | $3.9B+2.9% |
| R&D Expenses | $433.0M+14.6% | $412.0M+2.2% | $387.0M+2.1% | $438.0M-0.9% | $378.0M-1.3% | $403.0M+3.1% | $379.0M+3.0% | $442.0M |
| SG&A Expenses | $2.2B+8.4% | $2.1B-12.2% | $1.9B+0.1% | $2.0B+0.1% | $2.0B-3.3% | $2.4B+26.3% | $1.9B+2.8% | $2.0B |
| Operating Income | $1.2B+7.9% | $1.1B+48.3% | $1.3B+5.5% | $1.5B+5.4% | $1.2B+20.5% | $760.0M-34.9% | $1.3B-2.9% | $1.4B+6.6% |
| EBITDA | $2.0B+10.7% | $1.8B+30.3% | $2.0B+5.7% | $2.1B+5.2% | $1.8B+14.7% | $1.4B-21.6% | $1.9B-1.7% | $2.0B |
| Interest Expense | $135.0M+101.5% | $107.0M+50.7% | $63.0M-12.5% | $55.0M-9.8% | $67.0M-23.0% | $71.0M+9.2% | $72.0M+10.8% | $61.0M |
| Income Tax | -$75.0M-144.6% | $208.0M+108.0% | $206.0M+17.7% | $190.0M-17.0% | $168.0M+5.7% | $100.0M-43.2% | $175.0M-4.4% | $229.0M |
| Net Income | $1.2B+36.0% | $870.0M+56.8% | $1.0B+7.9% | $1.2B+10.2% | $908.0M+11.0% | $555.0M-38.8% | $954.0M-12.3% | $1.1B+0.6% |
| EPS (Basic) | $1.75+36.7% | $1.23+59.7% | $1.45+9.0% | $1.69+12.7% | $1.28+13.3% | $0.77-37.4% | $1.33-9.5% | $1.50+2.7% |
| EPS (Diluted) | $1.75+37.8% | $1.23+59.7% | $1.45+9.8% | $1.68+12.8% | $1.27+13.4% | $0.77-36.9% | $1.32-9.0% | $1.49+2.8% |
| Diluted Shares (Avg) | 707M-1.0% | 708M-1.6% | 711M-1.3% | N/A | 714M-2.2% | 719M-3.1% | 721M-3.7% | N/A |
DHR Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $93.3B+16.8% | $92.4B+13.2% | $83.5B+5.6% | $83.5B+7.6% | $79.9B-0.9% | $81.6B+3.9% | $79.1B-5.1% | $77.5B-8.2% |
| Current Assets | $14.8B+53.9% | $13.4B+21.7% | $13.9B+46.3% | $12.8B+34.3% | $9.6B-4.5% | $11.0B+14.5% | $9.5B-33.7% | $9.5B-31.9% |
| Cash & Equivalents | $5.7B+271.9% | $4.3B+47.0% | $5.7B+186.1% | $4.6B+122.1% | $1.5B-41.8% | $3.0B+24.6% | $2.0B-71.7% | $2.1B-64.6% |
| Inventory | $3.1B+17.2% | $3.3B+21.2% | $2.6B+3.0% | $2.5B+6.8% | $2.7B-0.1% | $2.7B+0.7% | $2.5B-4.3% | $2.3B-10.2% |
| Accounts Receivable | $4.1B+9.9% | $4.0B+11.3% | $3.8B+8.9% | $3.9B+10.6% | $3.8B+7.1% | $3.6B+8.1% | $3.5B+3.8% | $3.5B-9.8% |
| Goodwill | $47.3B+10.2% | $47.4B+10.3% | $42.8B+2.7% | $43.2B+6.6% | $42.9B+1.8% | $43.0B+5.4% | $41.7B+2.0% | $40.5B-2.7% |
| Total Liabilities | $39.7B+37.6% | $39.8B+35.9% | $30.6B+8.2% | $30.9B+10.5% | $28.8B-1.7% | $29.3B+2.2% | $28.3B-5.7% | $28.0B-9.7% |
| Current Liabilities | $9.1B+43.1% | $8.1B+19.3% | $7.5B+12.3% | $6.8B+0.1% | $6.3B-13.8% | $6.8B+1.4% | $6.6B-14.6% | $6.8B-17.8% |
| Non-Current Liabilities | $30.6B+36.0% | $31.7B+40.8% | $23.1B+7.0% | $24.1B+13.8% | $22.5B+2.4% | $22.5B+2.4% | $21.6B-2.5% | $21.2B-6.7% |
| Long-Term Debt | $24.4B+44.9% | $25.1B+49.2% | $17.6B+9.9% | $18.4B+18.8% | $16.8B+3.1% | $16.9B+3.3% | $16.0B-2.7% | $15.5B-7.2% |
| Total Equity | $53.6B+5.0% | $52.6B+0.5% | $52.9B+4.1% | $52.5B+6.0% | $51.1B-0.4% | $52.3B+4.9% | $50.8B-4.9% | $49.5B-7.4% |
| Retained Earnings | $49.2B+7.1% | $48.2B+6.6% | $47.6B+6.1% | $46.9B+6.1% | $45.9B+6.1% | $45.2B+6.0% | $44.9B+7.0% | $44.2B+7.6% |
Not reported in any period shown, so not listed: Short-Term Investments, Long-Term Investments.
DHR Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.9B+13.5% | $1.5B+14.6% | $1.3B+1.8% | $2.1B+4.9% | $1.7B+9.8% | $1.3B-5.6% | $1.3B-25.3% | $2.0B+24.7% |
| Depreciation & Amortization | $721.0M+15.9% | $659.0M+7.9% | $627.0M+6.1% | $623.0M+4.7% | $622.0M+5.2% | $611.0M+5.3% | $591.0M+0.9% | $595.0M |
| Stock-Based Compensation | $115.0M+38.6% | $93.0M+2.2% | $58.0M-4.9% | N/A | $83.0M-1.2% | $91.0M+4.6% | $61.0M+1.7% | N/A |
| Capital Expenditures | $255.0M-12.7% | $269.0M+8.5% | $237.0M-3.3% | $371.0M-28.1% | $292.0M-2.0% | $248.0M-13.6% | $245.0M-15.8% | $516.0M+18.9% |
| Free Cash Flow | $1.6B+19.1% | $1.3B+16.1% | $1.1B+2.9% | $1.7B+16.2% | $1.4B+12.8% | $1.1B-3.5% | $1.1B-27.2% | $1.5B+26.8% |
| Investing Cash Flow | -$300.0Mn/m | -$10.1Bn/m | -$249.0Mn/m | -$384.0Mn/m | -$312.0Mn/m | -$258.0Mn/m | -$242.0Mn/m | -$694.0Mn/m |
| Financing Cash Flow | -$262.0Mn/m | $7.3Bn/m | $46.0Mn/m | $1.3Bn/m | -$2.8Bn/m | -$247.0Mn/m | -$1.3Bn/m | -$1.7Bn/m |
| Dividends Paid | $281.0M+22.7% | $283.0M+23.6% | $226.0M+16.5% | $226.0M+15.9% | $229.0M+16.8% | $229.0M+14.5% | $194.0M+9.6% | $195.0M-2.5% |
| Share Buybacks | $0-100.0% | $894.0Mn/m | $0-100.0% | $0-100.0% | $2.0B+214.1% | $0-100.0% | $1.1Bn/m | $809.0Mn/m |
DHR Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | Q3'2610-Q | Q2'2610-Q | Q1'2610-Q | Q4'2510-K | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 58.5%+0.3pp | 57.6%-1.7pp | 60.3%-0.8pp | 58.0%-1.5pp | 58.2%-0.5pp | 59.4%-0.3pp | 61.2%+1.0pp | 59.5%+0.5pp |
| Operating Margin | 19.0%-0.1pp | 18.0%+5.2pp | 22.6%+0.4pp | 22.0%+0.2pp | 19.1%+2.5pp | 12.8%-7.5pp | 22.2%-0.5pp | 21.8%+0.9pp |
| Net Margin | 18.8%+3.8pp | 13.9%+4.5pp | 17.3%+0.7pp | 17.5%+0.9pp | 15.0%+0.9pp | 9.3%-6.4pp | 16.6%-2.2pp | 16.6%-0.2pp |
| Return on Equity | 2.3%+0.5pp | 1.7%+0.6pp | 1.9%+0.1pp | 2.3%+0.1pp | 1.8%+0.2pp | 1.1%-0.8pp | 1.9%-0.2pp | 2.2%+0.2pp |
| Return on Assets | 1.3%+0.2pp | 0.9%+0.3pp | 1.2%0.0pp | 1.4%0.0pp | 1.1%+0.1pp | 0.7%-0.5pp | 1.2%-0.1pp | 1.4%+0.1pp |
| Current Ratio | 1.63+0.1x | 1.650.0x | 1.87+0.4x | 1.87+0.5x | 1.52+0.1x | 1.62+0.2x | 1.43-0.4x | 1.40-0.3x |
| Debt-to-Equity | 0.45+0.1x | 0.48+0.2x | 0.330.0x | 0.350.0x | 0.330.0x | 0.320.0x | 0.310.0x | 0.310.0x |
| Liabilities-to-Equity | 0.74+0.2x | 0.76+0.2x | 0.580.0x | 0.590.0x | 0.560.0x | 0.560.0x | 0.560.0x | 0.570.0x |
| Asset Turnover | 0.070.0x | 0.070.0x | 0.070.0x | 0.080.0x | 0.080.0x | 0.070.0x | 0.070.0x | 0.080.0x |
| FCF Margin | 24.9%+2.3pp | 20.2%+1.8pp | 18.2%-0.1pp | 25.5%+2.5pp | 22.6%+1.7pp | 18.4%-1.3pp | 18.4%-6.6pp | 23.0%+4.5pp |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Danaher Corporation DHR | FY2025 | $24.6B | $3.6B | 14.7% | $163.8B | 59/100 |
| Thermo Fisher Scientific Inc. TMO | FY2025 | $44.6B | $6.7B | 15.0% | $253.2B | 58/100 |
| Idexx Laboratories Inc IDXX | FY2025 | $4.3B | $1.1B | 24.6% | $44.9B | 75/100 |
| Agilent Technologies Inc. A | FY2025 | $6.9B | $1.3B | 18.8% | $49.6B | 67/100 |
| Mettler-Toledo International MTD | FY2025 | $4.0B | $869.2M | 21.6% | $33.5B | 59/100 |
| Labcorp Holdings Inc. LH | FY2025 | $14.0B | $876.5M | 6.3% | $26.8B | 50/100 |
Where Danaher Corporation Ranks
Frequently Asked Questions
What is Danaher Corporation's annual revenue?
Danaher Corporation (DHR) reported $24.6B in total revenue for fiscal year 2025. This represents a 2.9% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
How fast is Danaher Corporation's revenue growing?
Danaher Corporation (DHR) revenue grew by 2.9% year-over-year, from $23.9B to $24.6B in fiscal year 2025.
Is Danaher Corporation profitable?
Yes, Danaher Corporation (DHR) reported a net income of $4.3B over the trailing 12 months to September 25, 2026. In fiscal year 2025 it reported a net income of $3.6B, with a net profit margin of 14.7%.
What is Danaher Corporation's EBITDA?
Danaher Corporation (DHR) had EBITDA of $7.1B in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.
How much debt does Danaher Corporation have?
As of fiscal year 2025, Danaher Corporation (DHR) had $4.6B in cash and equivalents against $18.4B in long-term debt.
What is Danaher Corporation's gross margin?
Danaher Corporation (DHR) had a gross margin of 59.1% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.
What is Danaher Corporation's operating margin?
Danaher Corporation (DHR) had an operating margin of 19.1% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.
What is Danaher Corporation's net profit margin?
Danaher Corporation (DHR) had a net profit margin of 14.7% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.
What is Danaher Corporation's return on equity (ROE)?
Danaher Corporation (DHR) has a return on equity of 6.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.
What is Danaher Corporation's free cash flow?
Danaher Corporation (DHR) generated $5.3B in free cash flow during fiscal year 2025. This represents a -0.7% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
What is Danaher Corporation's operating cash flow?
Danaher Corporation (DHR) generated $6.4B in operating cash flow during fiscal year 2025, representing cash generated from core business activities.
What are Danaher Corporation's total assets?
Danaher Corporation (DHR) had $83.5B in total assets as of fiscal year 2025, including both current and long-term assets.
What are Danaher Corporation's capital expenditures?
Danaher Corporation (DHR) invested $1.2B in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.
How much does Danaher Corporation spend on research and development?
Danaher Corporation (DHR) invested $1.6B in research and development during fiscal year 2025.
What is Danaher Corporation's current ratio?
Danaher Corporation (DHR) had a current ratio of 1.87 as of fiscal year 2025, which is generally considered healthy.
What is Danaher Corporation's debt-to-equity ratio?
Danaher Corporation (DHR) had a debt-to-equity ratio of 0.35 as of fiscal year 2025. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
What is Danaher Corporation's liabilities-to-equity ratio?
Danaher Corporation (DHR) had a liabilities-to-equity ratio of 0.59 as of fiscal year 2025, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
What is Danaher Corporation's return on assets (ROA)?
Danaher Corporation (DHR) had a return on assets of 4.3% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.
What is Danaher Corporation's P/E ratio?
Danaher Corporation (DHR) trades at 37.8x earnings, its market capitalization divided by $4.3B net income, trailing 12 months to September 25, 2026. The market capitalization is $163.8B as of Oct 26, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Danaher Corporation's price-to-sales ratio?
Danaher Corporation (DHR) trades at 6.4x sales, its market capitalization divided by $25.6B revenue, trailing 12 months to September 25, 2026. The market capitalization is $163.8B as of Oct 26, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.
What is Danaher Corporation's Altman Z-Score?
Danaher Corporation (DHR) has an Altman Z-Score of 4.53, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
What is Danaher Corporation's Piotroski F-Score?
Danaher Corporation (DHR) has a Piotroski F-Score of 5 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Are Danaher Corporation's earnings high quality?
Danaher Corporation (DHR) has an earnings quality ratio of 1.78x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Can Danaher Corporation cover its interest payments?
Danaher Corporation (DHR) has an interest coverage ratio of 17.70x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.
How financially healthy is Danaher Corporation?
Danaher Corporation (DHR) scores 59 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.